Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.
To Observe and Evaluate the Efficacy and Safety of Apatinib in Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.
Cervical Cancer
DRUG: Apatinib
Apatinib treating patients with advanced cervical cancer after radiotherapy and first-line chemotherapy., The time from the beginning of treatment to observing the progression of the disease or the death of any cause., 12 week
Eligible patients will receive apatinib treatment until disease progression or intolerable toxicity or patients withdrawal of consent after the failure of chemotherapy or radiotherapy.